Completed
Isoprinosine Effect on Immunologic Defects and Clinical Changes in AIDS Patients
What is being tested
Inosine pranobex
Drug
Who is being recruted
Blood-Borne Infections+14
+ Urogenital Diseases
+ Genital Diseases
Over 18 Years
+5 Eligibility Criteria
How is the trial designed
Treatment Study
Interventional
Summary
Principal SponsorNewport Pharmaceuticals International
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner
This study focuses on the effects of a drug called Isoprinosine (Inosiplex) in patients diagnosed with AIDS. The main goal is to understand how this drug impacts the immune system and overall health of these patients. The study involves individuals with AIDS, aiming to address the challenges associated with this condition and potentially improve their care. The importance of this study lies in its potential to uncover new treatment options and strategies for managing AIDS.
Principal SponsorNewport Pharmaceuticals International
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Blood-Borne InfectionsUrogenital DiseasesGenital DiseasesCommunicable DiseasesImmunologic Deficiency SyndromesImmune System DiseasesInfectionsRetroviridae InfectionsRNA Virus InfectionsSexually Transmitted DiseasesSlow Virus DiseasesVirus DiseasesSexually Transmitted Diseases, ViralLentivirus InfectionsAcquired Immunodeficiency SyndromeAIDS-Related ComplexHIV Infections
Criteria
5 exclusion criteria prevent from participating
Patients with severe AIDS and specified laboratory immunologic defects.
Patients receiving steroids, cytotoxic immunosuppressive agents, radiotherapy.
Patients who have received any other immunotherapy.
Critically ill patients.
Show More Criteria
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Newport Pharmaceuticals International Inc
Laguna Hills, United StatesOpen Newport Pharmaceuticals International Inc in Google MapsCompletedOne Study Center